Used as a research compound in neuroscience for its anxiolytic properties, demonstrating potential in studying anxiety-related pathways without the sedative effects typical of benzodiazepines. It acts as a partial agonist at the benzodiazepine binding site on GABA_A receptors, making it valuable in exploring the role of GABAergic transmission in mood and behavior. Due to its unique pharmacological profile, it has been utilized in preclinical studies to investigate novel mechanisms for treating anxiety disorders and depression. However, it is not used clinically and remains primarily a tool in experimental pharmacology.